Cysteine cathepsins and the skeleton

Clinical Reviews in Bone and Mineral Metabolism

Volumn 9, Issue 2, 2011, Pages 83-93

  Brömme, Dieter ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arthritis; Cathepsin K; Cathepsins; Collagenase; Cysteine protease inhibitors; Odanacatib; Osteoporosis

Indexed keywords

ALENDRONIC ACID; BALICATIB; BISPHOSPHONIC ACID DERIVATIVE; CATHEPSIN; CATHEPSIN B; CATHEPSIN F; CATHEPSIN H; CATHEPSIN K; CATHEPSIN K INHIBITOR; CATHEPSIN L; CATHEPSIN S; CATHEPSIN S INHIBITOR; CATHEPSIN V; CATHEPSIN X; COLLAGEN TYPE 2; COLLAGENASE; DIPEPTIDYL PEPTIDASE I; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; ODANACATIB; ONO 5334; RELACATIB; SB 55348; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE DENSITY; BONE REMODELING; BREAST CANCER; COLLAGEN DEGRADATION; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; ENZYME ACTIVITY; HUMAN; IMMUNOREGULATION; INFLAMMATION; JOINT DESTRUCTION; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOCLAST ACTIVITY; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SCLERODERMA;

EID: 79960071578     PISSN: 15348644     EISSN: 15590119     Source Type: Journal    
DOI: 10.1007/s12018-011-9101-y     Document Type: Article

References (129)

1. vonder Mark K. Structure and biosynthesis of collagens. In: Seibel M, Robins S, Bilezikian J, editors. San Diego: Academic Press; 1999.
2. Robins S. Fibrillogenesis and maturation of collagens in Dynamics of bone and cartilage metabolism. In: Seiber M, Robins S, Bilezikian J, editors. San Diego: Academic Press; 1999.
3. JJ Reynolds 1996 Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation Oral Dis 2 70 76 8957940 1:STN:280:DyaK2s7hs1ymtw%3D%3D (Pubitemid 126602152)
4. KA Mookhtiar, et al. 1992 Clostridium histolyticum collagenases: a new look at some old enzymes Matrix Suppl 1 116 126 1336107 1:STN:280: DyaK3s7isFegsA%3D%3D
5. D Brömme, et al. 1996 Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme J Biol Chem 271 2126 2132 8567669
6. MF French, et al. 1992 Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability J Protein Chem 11 83 97 1325154 1:CAS:528:DyaK38XisFSlurg%3D
7. P Garnero, et al. 1998 The collagenolytic activity of cathepsin K is unique among mammalian proteinases J Biol Chem 273 32347 32352 9822715 1:CAS:528:DyaK1cXnvVelu7c%3D (Pubitemid 29177183)
8. MC Burleigh, et al. 1974 Cathepsin B1. A lysosomal enzyme that degrades native collagen Biochem J 137 387 398 4207388 1:CAS:528:DyaE2cXktVSktbw%3D
9. DJ Etherington, et al. 1977 The action of cathepsin B and collagenolytic cathepsin in the degradation of collagen Acta Biol Med Ger 36 1555 1563 29420 1:CAS:528:DyaE1cXlsVamsrk%3D (Pubitemid 8378343)
10. S Gal, et al. 1986 The major excreted protein of transformed fibroblasts is an activable acid-protease J Biol Chem 261 1760 1765 3511049 1:CAS:528:DyaL28Xos1altw%3D%3D (Pubitemid 17205010)
11. K Tezuka, et al. 1994 Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts J Biol Chem 269 1106 1109 8288568 1:CAS:528:DyaK2cXis1Cntrc%3D (Pubitemid 24032492)
12. MJ Bossard, et al. 1996 Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification J Biol Chem 271 12517 12524 8647860 1:CAS:528:DyaK28XjtFantrc%3D (Pubitemid 26160924)
13. R Willstaetter, et al. 1929 Ueber die Proteasen der Magenschleimhaut Hoppe-Seyler's Z Physiol Chem 180 127 143
14. RW Mason 2008 Emerging functions of placental cathepsins Placenta 29 385 390 18359513 1:CAS:528:DC%2BD1cXlvVSguro%3D
15. B Wiederanders, et al. 2003 Functions of propeptide parts in cysteine proteases Curr Protein Pept Sci 4 309 326 14529526 1:CAS:528: DC%2BD3sXot1WksLg%3D (Pubitemid 37236346)
16. L Polgar, et al. 1982 Current problems in mechanistic studies of serine and cysteine proteinases Biochem J 207 1 10 6758764 1:CAS:528:DyaL3sXhtVeisb8%3D
17. GW Mellor, et al. 1993 Ionization characteristics of the Cys-25/His-159 interactive system and of the modulatory group of papain: resolution of ambiguity by electronic perturbation of the quasi-2-mercaptopyridine leaving group in a new pyrimidyl disulphide reactivity probe Biochem J 290 Pt 1 289 296 8439297 1:CAS:528:DyaK3sXktVerurw%3D (Pubitemid 23081231)
18. D Musil, et al. 1991 The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity EMBO J 10 2321 2330 1868826 1:CAS:528:DyaK3MXlsFertLc%3D (Pubitemid 121000005)
19. G Guncar, et al. 1999 Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S EMBO J 18 793 803 10022822 1:CAS:528: DyaK1MXhs1WrsrY%3D (Pubitemid 29082259)
20. ME McGrath, et al. 1997 Crystal structure of human cathepsin K complexed with a potent inhibitor Nat Struct Biol 4 105 109 9033587 1:CAS:528: DyaK2sXhtVait7k%3D (Pubitemid 27066383)
21. ME McGrath, et al. 1998 Crystal structure of human cathepsin S Protein Sci 7 1294 1302 9655332 1:CAS:528:DyaK1cXjvFGqsro%3D (Pubitemid 28272896)
22. JR Somoza, et al. 2000 Crystal structure of human cathepsin V Biochemistry 39 12543 12551 11027133 1:CAS:528:DC%2BD3cXms1ShsLk%3D
23. JR Somoza, et al. 2002 The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators J Mol Biol 322 559 568 12225749 1:CAS:528:DC%2BD38Xmslalsrc%3D
24. G Guncar, et al. 1998 Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function Structure 6 51 61 9493267 1:CAS:528:DyaK1cXhtVGltL0%3D (Pubitemid 28084399)
25. G Guncar, et al. 2000 Crystal structure of cathepsin X: a flip-flop of the ring of His23 allows carboxy-monopeptidase and carboxy-dipeptidase activity of the protease Structure 8 305 313 10745011 1:CAS:528:DC%2BD3cXitVOqtLw%3D (Pubitemid 30148696)
26. A Molgaard, et al. 2007 The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2 Biochem J 401 645 650 17020538 (Pubitemid 46219258)
27. RJ Riese, et al. 2000 Cathepsins and compartmentalization in antigen presentation Curr Opin Immunol 12 107 113 10679409 1:CAS:528: DC%2BD3cXhsVOkurc%3D (Pubitemid 30093458)
28. GP Shi, et al. 2000 Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages J Exp Med 191 1177 1186 10748235 1:CAS:528:DC%2BD3cXit1ygurg%3D
29. E Tolosa, et al. 2003 Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis J Clin Invest 112 517 526 12925692 1:CAS:528:DC%2BD3sXms1Wntbk%3D (Pubitemid 38056336)
30. CT Pham, et al. 1999 Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo Proc Natl Acad Sci USA 96 8627 8632 10411926 1:CAS:528:DyaK1MXkslOkt7k%3D (Pubitemid 29354842)
31. C Linnevers, et al. 1997 Human cathepsin W, a putative cysteine protease predominantly expressed in CD8 + T-lymphocytes FEBS Lett 405 253 259 9108299 1:CAS:528:DyaK2sXitVKrs7k%3D (Pubitemid 27138486)
32. T Wex, et al. 2001 Human cathepsin W, a cysteine protease predominantly expressed in NK cells, is mainly localized in the endoplasmic reticulum J Immunol 167 2172 2178 11490002 1:CAS:528:DC%2BD3MXlvFequ7o%3D (Pubitemid 32747527)
33. G Velasco, et al. 1994 Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues J Biol Chem 269 27136 27142 7929457 1:CAS:528:DyaK2MXot1Krug%3D%3D
34. D Bromme, et al. 1995 Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution Biol Chem Hoppe Seyler 376 379 384 7576232 1:CAS:528:DyaK2MXms1Wgu78%3D
35. FH Drake, et al. 1996 Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts J Biol Chem 271 12511 12516 8647859 1:CAS:528:DyaK28XjtFantrY%3D (Pubitemid 26160923)
36. WS Hou, et al. 2001 Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation Am J Pathol 159 2167 2177 11733367 1:CAS:528:DC%2BD38XhslaqtQ%3D%3D
37. W-S Hou, et al. 2002 Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium Arthritis Rheum 46 663 674 11920402 1:CAS:528:DC%2BD38XisFOmt7g%3D (Pubitemid 34214249)
38. C Tepel, et al. 2000 Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin J Cell Sci 113 4487 4498 11082042 1:CAS:528:DC%2BD3MXmsVKmuw%3D%3D (Pubitemid 32117909)
39. F Buhling, et al. 2000 Cathepsin K expression in human lung Adv Exp Med Biol 477 281 286 10849755 1:CAS:528:DC%2BD3cXos1yhu78%3D (Pubitemid 32174014)
40. F Buhling, et al. 2001 Cathepsin K-a marker of macrophage differentiation? J Pathol 195 375 382 11673837 1:CAS:528:DC%2BD3MXotlGqu7g%3D
41. V Everts, et al. 1996 Phagocytosis and intracellular digestion of collagen, its role in turnover and remodeling Histochem J 28 229 245 8762055 1:CAS:528:DyaK28XktlaktLk%3D (Pubitemid 26178396)
42. V Everts, et al. 1985 The digestion of phagocytosed collagen is inhibited by the proteinase inhibitors leupeptin and E-64 Coll Relat Res 5 315 336 4053562 1:CAS:528:DyaL2MXlslKru7s%3D (Pubitemid 15237174)
43. H Kirschke, et al. 1986 Cathepsin S. The cysteine proteinase from bovine lymphoid tissue is distinct from cathepsin L (EC 3.4.22.15) Biochem J 240 455 459 3814093 1:CAS:528:DyaL2sXitFaq (Pubitemid 17196136)
44. D Bromme, et al. 1993 Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme J Biol Chem 268 4832 4838 8444861 1:STN:280:DyaK3s7os1Orug%3D%3D (Pubitemid 23081601)
45. YT Konttinen, et al. 2002 Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis Arthritis Rheum 46 953 960 11953972 1:CAS:528: DC%2BD38Xjs12lt7g%3D (Pubitemid 34303807)
46. J Rozhin, et al. 1994 Pericellular pH affects distribution and secretion of cathepsin B in malignant cells Cancer Res 54 6517 6525 7987851 1:CAS:528:DyaK2MXislalsLg%3D
47. L Xia, et al. 1999 Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption cathepsin K-activity by peptidyl vinyl sulfones Biol Chem 380 679 687 10430032 1:CAS:528:DyaK1MXksVWgurs%3D (Pubitemid 29322358)
48. O Vasiljeva, et al. 2005 Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans FEBS Lett 579 1285 1290 15710427 1:CAS:528:DC%2BD2MXhtlOntbo%3D (Pubitemid 40248701)
49. JR Pungercar, et al. 2009 Autocatalytic processing of procathepsin B is triggered by proenzyme activity Febs J 276 660 668 19143833 1:CAS:528: DC%2BD1MXhs1Kit7c%3D
50. VY Reddy, et al. 1995 Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages Proc Natl Acad Sci USA 92 3849 3853 7731994 1:CAS:528: DyaK2MXlsVSlu7k%3D
51. S Jordans, et al. 2009 Monitoring compartment-specific substrate cleavage by cathepsins B, K, L, and S at physiological pH and redox conditions BMC Biochem 10 23 19772638
52. E Godat, et al. 2008 Regulation of cathepsin K activity by hydrogen peroxide Biol Chem 389 1123 1126 18979635 1:CAS:528:DC%2BD1cXps1Ohu7o%3D
53. DJ Buttle, et al. 1992 Lysosomal cysteine endopeptidases mediate interleukin 1-stimulated cartilage proteoglycan degradation Biochem J 287 657 661 1445226 1:CAS:528:DyaK38XmtFSntbs%3D
54. Q Li, et al. 1996 Gamma interferon induced increases in intracellular cathepsin B activity in PMA primed THP-1 cells are blocked by inhibitors of protein kinase C Immunopharmacol Immunotoxicol 18 375 396 8872491 (Pubitemid 26284204)
55. K Storm van's Gravesande, et al. 2002 IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression J Immunol 168 4488 4494 11970993
56. N Furuyama, et al. 2000 Distinct roles of cathepsin K and cathepsin L in osteoclastic bone resorption Endocr Res 26 189 204 10921447 1:CAS:528: DC%2BD3cXlsFWjtr4%3D (Pubitemid 30460839)
57. BR Troen 2006 The regulation of cathepsin K gene expression Ann N Y Acad Sci 1068 165 172 16831915 1:CAS:528:DC%2BD28XntFentbw%3D (Pubitemid 43824146)
58. Z Li, et al. 2000 Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates Biochemistry 39 529 536 10642177 1:CAS:528:DyaK1MXotFKgt70%3D (Pubitemid 30077626)
59. Z Li, et al. 2002 Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate J Biol Chem 277 28669 28676 12039963 1:CAS:528:DC%2BD38XmsVGqtLk%3D
60. Z Li, et al. 2004 Regulation of collagenase activities of human cathepsins by glycosaminoglycans J Biol Chem 279 5470 5479 14645229 1:CAS:528:DC%2BD2cXhtFeqtLc%3D (Pubitemid 38220571)
61. Z Li, et al. 2008 The crystal and molecular structures of a cathepsin K: chondroitin sulfate complex J Mol Biol 383 78 91 18692071 1:CAS:528: DC%2BD1cXhtFektr7O
62. Cherney MM et al. Activity and structure of cathepsin K variant M5 in complex with chondroitin sulfate. 2010.
63. Neufeld EF. The mucopolysaccharidoses. New YorK: McGraw-Hill; 2001.
64. S Wilson, et al. 2009 Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities Am J Pathol 175 2053 2062 19834056 1:CAS:528:DC%2BC3cXhslSjtb4%3D
65. SR Wilson, et al. 2009 Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption J Biol Chem 284 2584 2592 19028686 1:CAS:528:DC%2BD1MXlvFegsg%3D%3D
66. Delaisse JM, et al. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. Boca Raton: CRC Press; 1992.
67. W Kafienah, et al. 1998 Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix Biochem J 331 727 732 9560298 1:CAS:528:DyaK1cXjt12iu7s%3D (Pubitemid 28211893)
68. BD Gelb, et al. 1996 Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency Science 273 1236 1238 8703060 1:CAS:528: DyaK28Xltlajsrc%3D
69. Gelb BD, et al. Pycnodysostosis: cathepsin K deficiency. In: Sriver CR, Beaudet AL, Valle D, Sly WCS, editors. The metabolic and molecular bases of inherited diseases. New York: McGraw-Hill; 2001. p. 3453-68.
70. V Everts, et al. 2003 Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts Calcif Tissue Int 73 380 386 12874701 1:CAS:528:DC%2BD3sXos1als74%3D (Pubitemid 37409425)
71. V Everts, et al. 1985 Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis Calcif Tissue Int 37 25 31 3922593 1:STN:280:DyaL2M3gtFWrsg%3D%3D (Pubitemid 15102232)
72. P Saftig, et al. 1998 Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K-deficient mice Proc Natl Acad Sci USA 95 13453 13458 9811821 1:CAS:528:DyaK1cXnsVGhtL4%3D (Pubitemid 28522993)
73. RA Dodds, et al. 1998 Cathepsin K knockout mice develop osteopetrosis due to lack of full function in their osteoclasts Bone 32 Supplement S164
74. LC Hofbauer, et al. 1999 Osteopetrosis in cathepsin K-deficient mice Eur J Endocrinol 140 376 377 10229899 1:CAS:528:DyaK1MXjslegur8%3D (Pubitemid 29254000)
75. AL Boskey, et al. 2009 Ablation of cathepsin k activity in the young mouse causes hypermineralization of long bone and growth plates Calcif Tissue Int 84 229 239 19172215 1:CAS:528:DC%2BD1MXivVWksL8%3D
76. R Kiviranta, et al. 2005 Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio Bone 36 159 172 15664014 1:CAS:528:DC%2BD2MXkvVeruw%3D%3D (Pubitemid 40128284)
77. V Everts, et al. 1999 Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone FASEB J 13 1219 1230 10385612 1:CAS:528:DyaK1MXktlOrur8%3D (Pubitemid 29300367)
78. S Perez-Amodio, et al. 2006 Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity Calcif Tissue Int 79 245 254 17033726 1:CAS:528:DC%2BD28XhtFGjs7zM (Pubitemid 44673718)
79. R Kiviranta, et al. 2001 Accelerated turnover of metaphyseal trabecular bone in mice overexpressing cathepsin K J Bone Miner Res 16 1444 1452 11499867 1:CAS:528:DC%2BD3MXmtVOhtb0%3D (Pubitemid 32675196)
80. H Mano, et al. 1996 Mammalian mature osteoclasts as estrogen target cells Biochem Biophys Res Commun 223 637 642 8687448 1:CAS:528:DyaK28XjvFCrur4%3D (Pubitemid 26246125)
81. V Parikka, et al. 2001 Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts Endocrinology 142 5371 5378 11713237 1:CAS:528:DC%2BD3MXovVSms7o%3D (Pubitemid 33131970)
82. N Furuyama, et al. 2000 Regulation of collagenolytic cysteine protease synthesis by estrogen in osteoclasts Steroids 65 371 378 10899536 1:CAS:528:DC%2BD3cXkslSjtLg%3D (Pubitemid 30427334)
83. CV Gay, et al. 2000 Regulation of differentiated osteoclasts Crit Rev Eukaryot Gene Expr 10 213 230 11272465 1:CAS:528:DC%2BD3MXhtlynt7s%3D (Pubitemid 32155134)
84. N Verzijl, et al. 2000 Effect of collagen turnover on the accumulation of advanced glycation end products J Biol Chem 275 39027 39031 10976109 1:CAS:528:DC%2BD3cXptFSkurY%3D (Pubitemid 32058915)
85. SR Goldring 2003 Pathogenesis of bone and cartilage destruction in rheumatoid arthritis Rheumatology 42 Suppl 2 ii11 16 12817090 1:CAS:528:DC%2BD2MXhtVehtL%2FM
86. CJ Malemud 2006 Matrix metalloproteinases: role in skeletal development and growth plate disorders Front Biosci 11 1702 1715 16368549 1:CAS:528:DC%2BD28XislSnsL0%3D (Pubitemid 43253388)
87. A Baici, et al. 1995 Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage Ann Rheum Dis 54 281 288 7763106 1:STN:280:DyaK2M3otlertg%3D%3D
88. CJF van Noorden, et al. 1987 Localization of cathepsin B activity in fibroblasts and chondrocytes by continuous monitoring of the formation of a final fluorescent reaction product using 5-nitrosalicylaldehyde Histochem J 19 483 487 3440760 (Pubitemid 18001165)
89. RA Maciewicz, et al. 1990 Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L FEBS Lett 269 189 193 2387401 1:CAS:528:DyaK3cXlsFSjt7s%3D
90. JS Mort, et al. 1998 Cathepsin B: an alternative protease for the generation of an aggrecan'metalloproteinase' cleavage neoepitope Biochem J 335 491 494 9794785 1:CAS:528:DyaK1cXnsFekuro%3D (Pubitemid 28515398)
91. WS Hou, et al. 2003 Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation Biol Chem 384 891 897 12887056 1:CAS:528:DC%2BD3sXlslGnsbY%3D
92. Buttle DJ. Lysosomal Cysteine Endopeptidases in the degradation of cartilage and bone in immunopharmacology of joints and connective tissue. Academic Press: London; 1994. p. 225-43.
93. DJ Buttle, et al. 1993 Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation Arthritis Rheum 36 1709 1717 8250991 1:CAS:528:DyaK2cXis1Ogu70%3D (Pubitemid 23360011)
94. J Schedel, et al. 2004 Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis Gene Ther 11 1040 1047 15164093 1:CAS:528:DC%2BD2cXltVGgsbY%3D (Pubitemid 39023108)
95. A Baici, et al. 1995 Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage Ann Rheum Dis 54 289 297 7763107 1:STN:280:DyaK2M3otlertw%3D%3D
96. G Cunnane, et al. 1999 Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis Rheumatology 38 34 42 10334680 1:STN:280:DyaK1M3msFynuw%3D%3D (Pubitemid 29509654)
97. R Lemaire, et al. 1997 Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells Br J Rheumatol 36 735 743 9255106 1:CAS:528:DyaK2sXlsFCqsrY%3D
98. JP Morko, et al. 2004 Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis Ann Rheum Dis 63 649 655 15140771 1:CAS:528:DC%2BD2cXltFekurg%3D (Pubitemid 38658393)
99. A Ruettger, et al. 2008 Cathepsins B, K, and L are regulated by a defined collagen type II peptide via activation of classical protein kinase C and p38 MAP kinase in articular chondrocytes J Biol Chem 283 1043 1051 17991740 1:CAS:528:DC%2BD1cXhsFaktQ%3D%3D
100. VM Dejica, et al. 2008 Cleavage of type II collagen by cathepsin K in human osteoarthritic cartilage Am J Pathol 173 161 169 18511517 1:CAS:528:DC%2BD1cXptVGqu78%3D (Pubitemid 351947964)
101. Vinardell T et al. Evidence to suggest that cathepsin K degrades articular cartilage in naturally occurring equine osteoarthritis. Osteoarthritis Cartilage. 2008.
102. KM Hummel, et al. 1998 Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction J Rheumatol 25 1887 1894 9779840 1:CAS:528: DyaK1cXmvVentL8%3D (Pubitemid 28459300)
103. RA Dodds, et al. 1999 Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues Arthritis Rheum 42 1588 1593 10446855 1:CAS:528:DyaK1MXlsFynsbg%3D (Pubitemid 30263624)
104. HJ Salminen-Mankonen, et al. 2007 Role of cathepsin K in normal joints and in the development of arthritis Curr Drug Targets 8 315 323 17305509 1:CAS:528:DC%2BD2sXhs1ygsro%3D
105. JR Connor, et al. 2009 Protective effects of a cathepsin K inhibitor, SB-553484, in the canine partial medial meniscectomy model of osteoarthritis Osteoarthritis Cartilage 17 1236 1243 19361586 1:STN:280:DC%2BD1MrntVSitQ%3D%3D
106. J Morko, et al. 2005 Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K Arthritis Rheum 52 3713 3717 16329095 1:CAS:528:DC%2BD28XjvF2jsQ%3D%3D (Pubitemid 41798207)
107. U Schurigt, et al. 2008 Cathepsin K deficiency partially inhibits, but does not prevent, bone destruction in human tumor necrosis factor-transgenic mice Arthritis Rheum 58 422 434 18240253 1:CAS:528:DC%2BD1cXivFahtrk%3D (Pubitemid 351294877)
108. M Ainola, et al. 2008 Erosive arthritis in a patient with pycnodysostosis: an experiment of nature Arthritis Rheum 58 3394 3401 18975331
109. AR Pettit, et al. 2001 TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis Am J Pathol 159 1689 1699 11696430 1:STN:280:DC%2BD3Mnltl2rsA%3D%3D (Pubitemid 33062512)
110. EM Gravallese, et al. 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor Arthritis Rheum 43 250 258 10693863 1:STN:280:DC%2BD3c7lsFGgsg%3D%3D (Pubitemid 30395732)
111. RJ Riese, et al. 1996 Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading Immunity 4 357 366 8612130 1:CAS:528:DyaK28Xis1GmsL8%3D (Pubitemid 26174051)
112. RJ Riese, et al. 1998 Cathepsin S activity regulates antigen presentation and immunity J Clin Invest 101 2351 2363 9616206 1:CAS:528:DyaK1cXjvVWrtLs%3D (Pubitemid 28270429)
113. TY Nakagawa, et al. 1999 Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice Immunity 10 207 217 10072073 1:CAS:528:DyaK1MXhs1yms78%3D (Pubitemid 29115626)
114. SL Biroc, et al. 2001 Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor Arthritis Rheum 44 703 711 11263786 1:CAS:528:DC%2BD3MXislagsL0%3D (Pubitemid 32234630)
115. HH Otto, et al. 1997 Cysteine proteases and their inhibitors Chem Rev 97 133 171 11848867 1:CAS:528:DyaK2sXktFOhsA%3D%3D
116. D Bromme, et al. 2002 Thiol-dependent cathepsins: pathophysiological implications and recent advances in inhibitor design Curr Pharm Des 8 1639 1658 12132996 1:CAS:528:DC%2BD38XltlCqtb4%3D (Pubitemid 34752831)
117. DS Yamashita, et al. 2000 Cathepsin K and the design of inhibitors of cathepsin K Curr Pharm Des 6 1 24 10637370 1:CAS:528:DC%2BD3cXhtlSisrc%3D (Pubitemid 30395459)
118. Y Yasuda, et al. 2005 The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics Adv Drug Deliv Rev 57 973 993 15876399 1:CAS:528:DC%2BD2MXjvVKmsr8%3D (Pubitemid 40703885)
119. A Lee-Dutra, et al. 2011 Cathepsin S inhibitors: 2004-2010 Expert Opin Ther Pat 21 311 337 21342054 1:CAS:528:DC%2BC3MXitlaltLY%3D
120. S Kumar, et al. 2007 A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys Bone 40 122 131 16962401 1:CAS:528:DC%2BD28Xht12ktrrF (Pubitemid 44839339)
121. S Adami, et al. 2006 Effect of one year treatment with the cathepsin-K inhibitor, balicatib,on bone mineral density (BMD) in postmenopausal women with osteopenia/osteoporosis (abstract) J Bone Miner Res 21 S24
122. Runger TM et al. Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib. J Am Acad Dermatol. 2011.
123. Eastell R et al. Safety and efficacy of the Cathepsin K inhibitor, ONO-5334, in postmenopausal osteoporosis-the OCEAN study. J Bone Miner Res. 2011.
124. JY Gauthier, et al. 2008 The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K Bioorg Med Chem Lett 18 923 928 18226527 1:CAS:528:DC%2BD1cXhsFWktro%3D (Pubitemid 351179363)
125. SA Stoch, et al. 2009 Effect of the cathepsin K inhibitor odanacatib on bone resorption biomarkers in healthy postmenopausal women: two double-blind, randomized, placebo-controlled phase I studies Clin Pharmacol Ther 86 175 182 19421185 1:CAS:528:DC%2BD1MXovFOrt7c%3D
126. HG Bone, et al. 2010 Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density J Bone Miner Res 25 937 947 19874198
127. JA Eisman, et al. 2011 Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect J Bone Miner Res 26 242 251 20740685 1:CAS:528:DC%2BC3MXjt1Wru7g%3D
128. DC Bauer 2011 Discontinuation of odanacatib and other osteoporosis treatments: here today and gone tomorrow? J Bone Miner Res 26 239 241 21254231
129. AB Jensen, et al. 2010 The cathepsin K inhibitor odanacatib suppresses bone resorption in women with breast cancer and established bone metastases: results of a 4-week, double-blind, randomized, controlled trial Clin Breast Cancer 10 452 458 21147688 1:CAS:528:DC%2BC3MXjslCksA%3D%3D